Leptin-Upregulated Metastasis-Associated Protein 1 Promotes Vasculogenic Mimicry in Breast Cancer Cells

Area of Science:

• Oncology
• Molecular Biology
• Endocrinology

Background:

• Leptin, an adipose hormone, influences energy balance and cancer progression.
• Vasculogenic mimicry (VM) is a hallmark of aggressive tumors, enabling neovascularization.
• Metastasis-associated protein 1 (MTA1) is implicated in tumor progression and metastasis.

Purpose of the Study:

• To investigate the role of MTA1 in leptin-mediated vasculogenic mimicry in human breast cancer cells.
• To elucidate the signaling pathway involved in leptin-induced MTA1 expression and VM.

Main Methods:

• Quantitative real-time PCR and Western blot analysis to assess gene and protein expression.
• Inhibition studies using leptin receptor (Ob-R) blocker (Ob-R BP) and STAT3 inhibitor (AG490).
• Three-dimensional culture assay and MTA1 gene silencing to evaluate VM induction and suppression.

Main Results:

• Leptin upregulated MTA1 mRNA and protein expression in breast cancer cells.
• Leptin-induced MTA1 upregulation was dependent on the Ob-R/STAT3 signaling pathway.
• MTA1 overexpression induced VM and VM-related protein expression, while MTA1 silencing suppressed leptin-induced VM.

Conclusions:

• Leptin regulates MTA1 expression through the Ob-R/STAT3 pathway.
• MTA1 acts as a critical mediator in leptin-induced vasculogenic mimicry in breast cancer.
• Targeting the leptin-MTA1 axis may offer therapeutic strategies for breast cancer treatment.